View in EDS

Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer.

Saved in:

Bibliographic Details
Title:	Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer.
Authors:	Chen YW; Division of Hematology Oncology, Department of Medicine, University of California San Diego School of Medicine, San Diego, CA., Xiu J; Caris Life Sciences, Phoenix, AZ., Poorman KA; Caris Life Sciences, Phoenix, AZ., Ryan CJ; Memorial Sloan Ketter Cancer Center, New York, NY., Gilg B; Caris Life Sciences, Phoenix, AZ., Oberley MJ; Caris Life Sciences, Phoenix, AZ., Sura G; The University of Texas MD Anderson Cancer Center, Houston, TX., Sledge GW Jr; Caris Life Sciences, Phoenix, AZ., Zhao SG; University of Wisconsin Department of Human Oncology, Madison, WI., Tan A; Vanderbilt University School of Medicine, Nashville, TN., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McKay RR; Division of Hematology Oncology, Department of Medicine, University of California San Diego School of Medicine, San Diego, CA.
Source:	JCO precision oncology [JCO Precis Oncol] 2026 Mar; Vol. 10, pp. e2500756. Date of Electronic Publication: 2026 Mar 05.
Publication Type:	Journal Article
Journal Info:	Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2473-4284
DOI:	10.1200/PO-25-00756